Authors
Latest:
Q&A: Rachel Downes, MD, provides highlights from the GATHER1 and GATHER2 clinical trials for GADiscover how ellipsoid zone integrity predicts geographic atrophy growth rates in recent clinical trials, enhancing future treatment strategies.
Latest:
The Residency Report: Clinical insights from the iStent infinite trialA conversation with David S. Friedman, MD, PhD, on treating uncontrolled open-angle glaucoma in patients with limited options
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
50 years of ophthalmology: What changed the game (Part 1)In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.
Latest:
ARVO 2025: Analysis of AREDS oral micronutrient supplementation on geographic atrophy growthAt ARVO 2025, in Salt Lake City, Utah, Roger Goldberg, MD, MBA, talked about his presentation on the effect of AREDS vitamins in geographic atrophy.
Latest:
Mercy Ships delivers a lifeline for eye health in Africa’s remote communitiesThrough its ophthalmic program, Mercy Ships provides critical eye surgeries and trains local professionals, ensuring sustainable eye care for the future.
Latest:
ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma managementGlaucoma management is shifting toward earlier, drop-sparing interventions using sustained drug delivery and advanced laser technologies that improve outcomes and quality of life for both patients and physicians.
Latest:
Q&A: Brandon D. Ayres, MD, on streamlining anterior vitrectomy with a high-speed, small-gauge probe at ASCRS 2025Ayres shares insights on using a trocar-free, 27-gauge vitrector to improve surgeon comfort and patient safety in anterior vitrectomy
Latest:
Demodex Blepharitis in a Contact Lens Wearer: Treatment Plan and OutcomesA panelist discusses how treating demodex blepharitis with Lotilaner not only eliminates the anterior blepharitis symptoms but also improves meibomian gland function, with low recurrence rates after treatment and significant benefits for patient comfort and quality of life.
Latest:
Artificial intelligence enhances detection of neuro-ophthalmic disordersDeep learning discerns IIH, NAION, and normal eyes using single fundus image.
Latest:
Tools can detect corneal nerve damage earlyNoncontact esthesiometry screens for all levels of neurotrophic keratitis.
Latest:
Investigators research ocular health after space flightSpaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Latest:
Next-generation MGD: Patients in their 20s, 30s offer new perspectivesLong-term screen users and contact lens wearers in group face challenges.
Latest:
Blog: MRI findings of undereye filler and filler migrationHyaluronic acid fillers are used for undereye volume correction, detailing aging effects on facial anatomy, common complications, and optimal injection techniques. Imaging tools such as MRI can prove to be beneficial for patient assessment.
Latest:
ARVO 2025: Lipid metabolism altered by CFH (Y402H) polymorphism and chronic oxidative stress in iPSC-derived RPE cellsAt ARVO 2025, in Salt Lake City, Utah, Peng Shang, PhD, talked about her presentation on how the Y402H polymorphism of Complement Factor H (CFH), a major genetic risk factor for AMD, and chronic oxidative stress affect the lipid profile of retinal pigment epithelial (RPE) cells.
Latest:
The impact of preservatives on the ocular surface in patients with ocular hypertension or glaucomaWeighing the benefits and trade-offs of preserved versus preservative-free glaucoma treatments is key to optimizing long-term patient care.
Latest:
Case 3: Treating nAMD in the Presence of Geographic AtrophyRetina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Latest:
Two-year results of laser scleral microporationProcedure can reduce scleral biomechanical stiffness and rejuvenate dynamic range of focus.
Latest:
The Residency Report: Clinical insights from the iStent infinite trialA conversation with David S. Friedman, MD, PhD, on treating uncontrolled open-angle glaucoma in patients with limited options
Latest:
AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MDThe procedure offers a renewed approach to suprachoroidal drainage, with potential for both combined and standalone glaucoma surgery.
Latest:
A portable solution for high-definition slit lamp imagingTAKE-HOME: This affordable device allows the view through a slit lamp to be shared in real time or recorded, for teaching and reference purposes.
Latest:
Investigators research ocular health after space flightSpaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Latest:
A reviews of the TEASE-1 clinical trial with Benjamin Bakall, MD, PhDThe TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future treatments.
Latest:
Future of Intravitreal InjectionNadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.
Latest:
Final Thoughts on Case Presentations and Advanced TherapiesRetinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
Latest:
Advances in Phacoemulsification TechniquesA panelist discusses how different phacoemulsification technologies, including vacuum-based and fluid-based systems like the Quatera 700, impact surgical efficiency and chamber stability during cataract procedures, emphasizing the importance of optimized fluidics settings for safe outcomes.
Latest:
ASCRS 2025: Oluwatosin U. Smith, MD, champions early intervention and innovative glaucoma technologiesExplore innovative glaucoma treatments and technologies, including AI, home monitoring, and new surgical options, to enhance patient care.
Latest:
Standardizing terminology for clarity in refractive surgeryLanguage can drive understanding, trust, and better outcomes for patients
